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We investigated a strategy to ameliorate the motor
symptoms of rats that received 6-hydroxydopamine
(6-OHDA) lesions, a rodent model of Parkinson’s
disease, through transplantation of embryonic medial
ganglionic eminence (MGE) cells into the striatum.
During brain development, embryonic MGE cells
migrate into the striatum and neocortex where they
mature into GABAergic interneurons and play a key
role in establishing the balance between excitation
and inhibition. Unlike most other embryonic neurons,
MGE cells retain the capacity for migration and inte-
gration when transplanted into the postnatal and
adult brain. We performed MGE cell transplantation
into the basal ganglia of control and 6-OHDA-
lesioned rats. Transplanted MGE cells survived,
differentiated into GABA+ neurons, integrated into
host circuitry, and modifed motor behavior in both
lesioned and control rats. Our data suggest that
MGE cell transplantation into the striatum is a prom-
ising approach to investigate the potential benefits
of remodeling basal ganglia circuitry in neurodegen-
erative diseases.
INTRODUCTION
Parkinson’s disease (PD) affects approximately 150 per 100,000
people in Europe and the United States of America. PD is char-
acterized by motor impairments as well as cognitive and auto-
nomic dysfunction and disturbances in mood. Motor aspects
of PD, including resting tremor, rigidity, and bradykinesia, are
the earliest symptoms and have a significant impact on quality
of life. Existing treatments can attenuate the symptoms of PD
but there is no cure. The motor symptoms of PD result primarily238 Cell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc.from the loss of dopamine-containing neurons in the substantia
nigra pars compacta (SNc) that extend axonal projections to the
striatum and release dopamine (for review, see Litvan et al.,
2007). The SNc and the striatum belong to the basal ganglia,
a network of nuclei, which integrate inhibitory and excitatory
signals to control movement. Loss of SNc cells in PD reduces
the amount of dopamine release into the striatum, producing
a neurotransmitter imbalance that inhibits the output of the basal
ganglia and produces hypokinetic signs (for review, see DeLong
and Wichmann, 2007) associated with overactivity of the indi-
rect, striatal-pallidal pathway.
The striatum is composed of three classes of neurons. The
medium spiny neurons are GABAergic projection neurons that
account for 95% of striatal neurons, express calbindin and sub-
stance P, give rise to nearly all striatal outputs, and receive nearly
all the extrastriatal inputs (Tepper and Bolam, 2004). The large
spiny cholinergic neurons that account for 3%–4% of striatal
neurons are excitatory and modulate the sub- and suprathres-
hold responses of the medium spiny neurons to cortical and/or
thalamic inputs (Tepper and Bolam, 2004). The small spiny
neurons represent the remaining 1%–2% of striatal neurons in
the striatum. They are GABAergic interneurons and provide the
main source of inhibition for medium spiny neurons (Koo´s and
Tepper, 1999; Koos et al., 2004; Plenz and Kitai, 1998). There
are three subtypes of small spiny neurons based on the patterns
of marker expression: one subtype that expresses calretinin
(CR), a second subtype that expresses parvalbumin (PV), and
a third subtype that expresses somatostatin (Som), NADPH-
diaphorase, and NOS (Kawaguchi et al., 1995; Tepper and
Bolam, 2004). Each GABAergic interneuron produces a strong
inhibitory postsynaptic potential in medium spiny neurons that
influences the precise timing of action potential firing. Both
excitatory and inhibitory striatal interneurons are important
sites of action for neuromodulators in the striatum and act in dif-
ferent but complementary ways to modify the activity of the
medium spiny projection neurons (Tepper and Bolam, 2004).
Striatal neurons originate from the embryonic primordium
of the basal ganglia, the ganglionic eminences. Inhibitory
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MGE Cells Modify Striatal-Dependent BehaviorGABAergic and cholinergic interneurons are believed to derive
from the medial ganglionic eminence (MGE) and perhaps the
preoptic area (Anderson et al., 1997b; Deacon et al., 1994;
Olsson et al., 1995; Zhao et al., 2003). GABAergic interneurons
may have mixed origins. The CR+ subclass of interneurons
derives mostly from the MGE, but as many as 10% may be
derived from the LGE (Marin et al., 2000). The PV+ subclass of
interneurons derives entirely from the MGE (Marin et al., 2000).
Transplantation studies suggest that Som+ interneurons may
originate from both the LGE and MGE (Olsson et al., 1998),
although the expression pattern of the transcription factor
Nkx2.1, which is required for the specification of MGE derivates,
suggests that Som+ cells are derived only from the MGE (Marin
et al., 2000). The embryonic MGE also produces a substantial
number of neocortical interneurons that migrate long distances
over a tangential pathway to the dorsal neocortex where they
mature into local circuit GABAergic interneurons (Anderson
et al., 1997a, 1999; Lavdas et al., 1999; Wichterle et al., 1999).
MGE cells retain the capacity for dispersal and integration
when transplanted heterochronically into neonatal or adult brain
(Grasbon-Frodl et al., 1997; Olsson et al., 1997; Wichterle et al.,
1999), develop into mature neurons when retransplanted into the
ganglionic eminences (Butt et al., 2005), and can significantly
increase the levels of inhibition exerted on neocortical projection
neurons when grafted into the neocortex (Alvarez-Dolado et al.,
2006).
The most widely used treatment for PD is administration of the
dopamine precursor levodopa, which improves motor behavior
but can also produce undesirable side effects including dyskine-
sias. Surgical approaches involve electrical stimulation or
ablation of the motor thalamus, the subthalamic nucleus (STN),
or the globus pallidus. Additional therapeutic strategies involve
transplantation of adult or embryonic dopamine-releasing tis-
sues or stem cells. However, these treatments have drawbacks,
and in some cases have produced disabling side effects (Piccini,
2002). We have investigated a novel approach to treating motor
symptoms in the 6-hydroxydopamine (6-OHDA) rat model of PD
via a nondopamine-based strategy to modify circuit activity in
the basal ganglia. We took advantage of the established pro-
perties of MGE cells and transplanted them into the striatum of
6-OHDA-treated rats to lower striatal activity. Transplanted MGE
cells migrated from the site of injection, dispersed throughout
the host striatum, acquired a mature neuronal phenotype, and
expressed neuronal and GABAergic markers. In addition, trans-
planted MGE cells expressed a variety of markers characteristic
of striatal GABAergic interneurons, including CB, CR, PV, and
Som. Finally, we show that the transplanted MGE cells became
physiologically mature, integrated into the host circuitry, and
improved the motor symptoms of 6-OHDA-treated rats. Our
results indicate that the transplantation of GABAergic interneu-
rons alters striatal circuitry in the rat 6-OHDA model of PD and
modifies the motor behavior of both lesioned and control rats.
RESULTS
MGE Cells Survive up to 1 Year after Transplantation
into the Adult Striatum
We dissected MGE cells expressing the GFP reporter protein
from embryonic day 14.5 (E14.5) rats, dissociated the cells,and transplanted them into the striatum of 6-OHDA rats. The
fate of the cells was determined at various time points after
transplantation (approximately 4000 cells obtained from 10
embryos). The MGE cells in suspension were analyzed prior to
transplantation via immunohistochemical markers. We found
that 75.1% ± 2.0% expressed the immature neuronal marker
MAP2, and 32.7% ± 1.4% expressed the mature neuronal
marker NeuN. Some cells expressed the inhibitory neurotrans-
mitter GABA (45.5% ± 2.1%) and the GABA synthesis enzyme
GAD67 (57.7% ± 2.9%). The dissociated MGE cells also
expressed striatal interneuronal markers such as calretinin (CR,
67.0% ± 2.9%), parvalbumin (PV, 51.9% ± 3.6%), somatostatin
(Som, 54.1% ± 2.9%), or the striatal projection marker calbindin
(CB, 44.8% ± 2%). Some of these markers were colocalized.
A small portion of the MGE cells expressed markers of precursor
cells such as Nestin (7.4% ± 1.3%), Ki67 (5.9% ± 1.0%), and 4A4
(2.1% ± 0.5%). We concluded that the injected cells were com-
posed primarily of immature or mature neurons (up to 75%) that
express striatal interneuronal or projection cell markers and
a minority of proliferating cells (up to 7%).
We injected approximately 250,000 cells into the striatum of
each animal and found that many of the transplanted cells did
not survive longer than 3 weeks after the transplantation. At 4
weeks after transplantation, approximately 1% (2613 ± 156) of
the transplanted cells remained. These cells persisted and their
number did not decrease further for up to 1 year after transplan-
tation. Our cell survival rate is similar to that reported by other
groups who have transplanted embryonic cells into adult rat
striatum after 6-OHDA lesions (see Terpstra et al., 2007). To
determine whether some of the MGE cells remained proliferative
after transplantation, we labeled fixed tissue with Ki67, a marker
expressed by dividing cells, and did not find Ki67+ MGE cells at
any time point after the transplantation (1, 2, and 4 days, 4 weeks,
8 weeks, and 12 weeks), indicating that the MGE cells ceased
dividing soon after transplantation.
Transplanted MGE Cells Migrate throughout
the Striatum
We examined the morphology of the surviving MGE cells at
several time points after transplantation. At 3 and 7 days post-
transplantation, GFP+ cells had moved away from the site of
injection and many had the characteristic morphology of
migrating neurons including an oblong soma with a leading
process and a trailing process. At 2 weeks posttransplanta-
tion, many of the GFP-MGE cells had migrated 2.0 to 2.5
mm in all directions from the site of transplantation and
some of the transplanted cells had migrated up to 3.5 mm.
At 2 weeks posttransplantation, the cells appeared more
mature with an oval soma and abundant neuritic processes.
The vast majority of the GFP+ cells were found in the striatum,
indicating that the MGE cells did not migrate beyond the
borders of the adult striatum (Figure 1A). The few cells found
in the cortex were probably derived from the injection track.
At 4 weeks posttransplantation, the majority of transplanted
MGE cells had a mature appearance with an oblong cell
body and multiple processes extending at least 50 mm from
the soma lesions (see Figure 1B). The transplanted cells had
very extensive and ramified processes that could be observed
as GFP+ fibers or puncta throughout the transplanted striatum.Cell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc. 239
Figure 1. Transplanted MGE Cells Migrated Long Distances from
the Site of Injection throughout the Striatum
(A) Striatum 4 weeks after transplantation. The transplanted GFP-MGE cells
migrated up to 2.5 mm in all directions from the sites of injection but did not
migrate beyond the borders of the striatum.
(B) Eight weeks after transplantation, the MGE cells had a mature appearance.
Most MGE cells had an oblong body shape and numerous processes that
could be traced up to hundreds of mm from the soma. The GFP+ processes
were present throughout the striatum even in areas far away from GFP-MGE
cell bodies. Scale bars represent 0.5 mm in (A) and 25 mm in (B).
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remote from the injection sites (Figure 1B). GFP+ neuritic
processes studied at higher magnification did not have spines,
suggesting that they were not medium spiny projection
neurons.
Most Transplanted MGE Cells Develop into Inhibitory
GABA+ Cells
We examined the fate of the transplanted MGE cells by quanti-
fying the percentage that expressed cell-specific markers at 4,240 Cell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc.8, and 12 weeks after transplantation. 4 weeks posttransplanta-
tion, the majority of the MGE cells expressed the mature
neuronal marker NeuN (75% ± 6%, n = 676 cells). We also found
that most of the transplanted cells expressed markers of
GABAergic neurons, including GABA (75% ± 4%, n = 294 cells),
the GABA-synthesizing enzyme GAD (60% ± 11%, n = 382 cells),
and the GABA transporter GAT1 (50% ± 9%, n = 380 cells), indi-
cating that the majority of MGE cells became GABAergic
neurons (Figure 2). Some of the MGE cells expressed markers
of striatal interneuron subtypes such as CR (8.3% ± 0.5%, n =
473 cells), PV (0.5% ± 0.5%, n = 320 cells), Som (1% ± 0.5%,
n = 300 cells), or nitric oxide synthase (NOS, 1% ± 0.7%, n =
337 cells). None of the transplanted MGE cells (n = 459 cells)
expressed the cholinergic interneuron marker ChAT, which
is expressed by striatal excitatory interneurons. Some MGE cells
expressed markers typical of striatal projection neurons such as
CB (24% ± 7%, n = 300 cells), but only at 4 weeks after trans-
plantation. The expression of CB by transplanted MGE cells
was transient, decreasing significantly by 8 weeks after trans-
plantation. Some transplanted MGE cells expressed substance
P (6% ± 2%, n = 193 cells; Figure 2) but were negative for
markers related to dopamine synthesis such as tyrosine hydrox-
ylase (TH), vesicular monoamine transporter 2 (VMAT), dopa-
mine transporter (DAT), or the marker of adult medium spiny
projection neurons, DARPP 32. However, half of the transplanted
MGE cells (49.43% ± 6%, n = 172 cells) expressed the transcrip-
tion factor NKX2.1, which is required for the specification of PV+
and SOM+ striatal interneurons. Together, these data indicate
that most MGE cells transplanted into adult striatum differenti-
ated into local GABAergic interneurons within 4 weeks and
expressed a range of cell-specific markers that are normally
expressed in the adult rat striatum.
We tested whether the pattern of marker expression of trans-
planted cells changed at later time points after transplantation.
We found that marker expression was preserved at 8 and 12
weeks with some notable exceptions. The percentage of MGE
cells that expressed Som rose from 1% to 10% ± 3% (n = 343
cells) by 12 weeks after transplantation. In addition, we found
that the percentage of MGE cells expressing the calcium binding
proteins was greatly reduced (CR, 2% ± 1%, n = 258 cells; CB,
2% ± 1.5%, n = 270 cells; PV, 0%, n = 136 cells). Interestingly,
we noted that close to the injection site, transplantation of the
MGE cells induced transient expression of CR and CB by host
striatal cells. At 4 weeks after transplantation, we noted strong
CR and CB expression in host cells, but this pattern of expres-
sion was not present 8 weeks after transplantation. Host cells
in control animals that received an injection of vehicle only did
not express CR or CB, indicating that the expression of CR
and CB in host cells was probabaly due to presence of the trans-
planted MGE cells. Thus, the expression of CB by the MGE
transplant cells that we noted at 4 weeks was not a strong indi-
cation that the MGE cells had differentiated into striatal projec-
tion neurons because both host and transplant cells expressed
CB transiently at 4 weeks, and because the vast majority of
MGE cells did not express CB at 8 weeks after transplantation
and at subsequent time points studied.
One fourth of the transplanted MGE cells (25% ± 4%) were
NeuN negative. The NeuN-negative cells stained positive for
the myelin protein, CNPase, suggesting that a subpopulation
Figure 2. Most MGE Cells Adopted an Inter-
neuronal Fate when Transplanted into the
Adult Striatum
(A) Four weeks after transplantation, most MGE
cells expressed the mature neuronal markers
NeuN (75% ± 6%).
(B–D) Most MGE cells also expressed markers
related to GABA storage or synthesis such as
GABA (B, 75% ± 4%), GAD (C, 60% ± 11%), and
GAT (D, 50% ± 9%).
(E–I) Some transplanted MGE cells also expressed
interneuron subtype markers CB (E, 24% ± 7%),
CR (F, 8.3% ± 0.5%), PV (G, 0.5% ± 0.5%),
Substance P (H, 6% ± 2%), and Somatostatin
(I, 1% ± 0.5%).
(J) One quarter of the MGE cells transplanted into
the striatum (25% ± 4%) expressed the oligoden-
drocyte marker CNPase. Arrows point to exam-
ples of MGE cells that stained positive for each
marker, and insets for each panel (labeled 2 and 3)
show higher power examples of immunopositive
cells.
Scale bar represents 30 mm in (A1) and applies to
lower-power images shown in (A1)–(J1); scale
bar represents 10 mm in (A2) and applies to all
higher-power inset images (A2–J2 and A3–J3).
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MGE cells that were transplanted into the striatum expressed
GFAP, indicating that transplanted cells did not differentiate
into astrocytes. The 3:1 ratio of neuronal to glial cells that we
observed at 4 weeks was maintained at 8 and 12 weeks post-
transplantation.
We also analyzed the cell soma size of transplanted MGE cells
that stained positive for cell-specific markers at 4 weeks after
transplantation (n = 660 cells obtained from 7 embryos): GFP-
CR+ cells were 25.6 ± 0.6 3 21.0 ± 0.5 mm, GFP-PV+ cells
were 26.6 ± 0.8 3 21.3 ± 0.6 mm, and GFP-CB+ were 21.3 ±
0.65 3 17.45 ± 0.5 mm. With the exception of CB+ cells thatCell Stem Cell 6, 238–2were relatively small, the size of CR+
and PV+ transplanted MGE cells was
similar to that of striatal host cells (CR+
cells = 23.5 ± 1.4 3 19.5 ± 1.5 mm, PV+
cells = 25.9 ± 0.9 3 20.2 ± 0.7 mm,
CB+ cells = 30.4 ± 0.6 3 23.6 ± 0.5 mm)
and similar to cell size previously reported
for striatal neurons in vivo (Kawaguchi
et al., 1995; Tepper and Bolam, 2004).
Thus, our data suggest that transplanted
MGE cells differentiated into cell types
similar to those of the host striatum.
Transplanted MGE Cells Integrate
into the Striatal Circuitry
We next examined whether the trans-
planted MGE cells established synaptic
connections and became functionally
integrated into the host striatum. We
found that 4 weeks after transplantation,
67% ± 3% of the GFP+ MGE cells(n = 193 cells) expressed synaptophysin puncta along their pro-
cesses, indicating the presence of synapses (Figure 3A). Electro-
physiological recordings provided further evidence that the MGE
cells became functionally integrated into the host striatum. We
obtained whole-cell patch-clamp recordings from the GFP+
MGE cells at 5 to 20 weeks after transplantation to examine their
basic membrane properties (n = 44 cells). We included Alexa-
594 dye in the patch electrodes to confirm that recordings
were obtained from targeted GFP-expressing transplant cells
or Texas Red dextran for morphological analysis of the recorded
cells (Figure 3B). Most of the transplanted MGE cells displayed
the physiological properties of neurons (37/44 cells): fast sodium50, March 5, 2010 ª2010 Elsevier Inc. 241
Figure 3. MGE Cells Transplanted into the Striatum Displayed the Basic Membrane Properties Characteristic of Mature Forebrain Interneu-
rons and Showed Evidence of Synaptic Integration
(A) 67% of the MGE cells (green) expressed the synapse marker synaptophysin (red) along their processes (white arrows).
(B) We obtained whole-cell patch-clamp recordings from transplanted cells up to 20 weeks after transplantation. Alexa-594 (red) was included in the fill solution of
the glass microelectrode to confirm that recordings were obtained from targeted GFP-expressing MGE transplant cells.
(C) Most MGE cells (37/44) fired repetitive nonaccommodating action potentials with large afterhyperpolarizations as is common for MGE-derived interneurons.
(D) A small percent of the transplanted MGE cells that were recorded from (n = 7/44) did not exhibit neuronal membrane properties and did not fire action poten-
tials when stimulated with a series of depolarizing currents, consistent with glial cell identity.
(E1) Most MGE neurons were fast spiking (FS) cells and did not fire rebound action potentials after hyperpolarization.
(E2) The FS population included stuttering FS cell subtypes.
(E3) The second most common cell type was low-threshold-spiking (LTS) cells. These cells displayed much lower spiking frequencies than did FS cells and dis-
played two or more rebound spikes in response to hyperpolarization.
(F) Transplanted cells demonstrated both AMPA and GABA-mediated spontaneous synaptic events.
(G) A transplanted MGE cell filled with Texas red-dextran demonstrated the branched aspiny processes that are characteristic of striatal interneurons.
Scale bars represent 3 mm in (A), 5 mm in (B), and 10 mm in (G).
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MGE Cells Modify Striatal-Dependent Behavioraction potentials blocked by TTX, relatively high input resis-
tances (324.6 ± 47.1 MU), and frequent spontaneous synaptic
activity (Figure 3C). The remaining 7/44 cells had properties
that were consistent with a glial phenotype: no fast currents,
very low input resistances (115.0 ± 13.4 MU), and no sponta-
neous synaptic inputs (Figure 3D). These data are consistent
with our immunohistochemical results.242 Cell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc.All recorded neurons (n = 37) displayed passive and active
properties consistent with forebrain GABAergic interneurons,
and the percentage breakdown of cells within interneuron sub-
types was consistent with our immunohistochemistry results.
The majority of transplanted MGE cells (50.0%) was fast-spiking
(FS) with low input resistances, fast time constants, and hyper-
polarized resting membrane potentials. These cells showed
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MGE Cells Modify Striatal-Dependent Behaviorextremely high-frequency firing with little adaptation and large
afterhyperpolarizations and did not fire rebound action poten-
tials after hyperpolarization (Figure 3E1). Within the FS cell
population were examples of both delayed FS and stuttering
FS cells (see Figure 3E2). The second most common cell type
we recorded were low-threshold-spiking cells (38.5%), also
known as burst-spiking nonpyramidal cells, which had higher
input resistances, slower time constants, and more depolarized
resting membrane potentials. These cells displayed much lower
spiking frequencies than FS cells and displayed two or more
rebound spikes in response to hyperpolarization (Figure 3E3).
Finally, rebound-regular-spiking nonpyramidal (R-RSNP) cells
were also encountered (7.7%). These cells had high input resis-
tances, long time constants, and hyperpolarized resting mem-
brane potentials. R-RSNP cells fired a single rebound spike in
response to hyperpolarization. We did not encounter nonre-
bounding RSNP cells while recording from the transplanted
MGE cells. One cell, which was omitted from classification, had
fast-spiking properties but a relatively high input resistance,
exceptionally strong hyperpolarization-activated cation current,
and extensive rebound spiking in response to hyperpolarization.
To segregate AMPAergic and GABAergic miniature synaptic
currents, TTX was bath-applied to isolate miniature synaptic
events while DNQX (to block AMPA events) and bicuculline (to
block GABAA receptor-mediated events) were locally applied.
The cells showed typical rates (1.9 ± 0.45 events/s) and ampli-
tudes (57.45 ± 0.95 pA) of miniature synaptic events and
received both glutamatergic and GABAergic inputs at a relative
frequency of about 1.5:1. Simultaneous application of DNQX
and bicuculline eliminated all miniature synaptic events (Fig-
ure 3F). Some of the cells were filled with Texas Red-dextran
for morphological analysis of recorded cells. Transplanted MGE
cells possessed numerous ramified processes that extended
hundreds of mm away from the cell body (Figure 3G). These
data suggest that the transplanted cells receive functional
synaptic inputs from local striatal inhibitory cells as well as
from excitatory cortical and/or thalamic cells, which provide
the main glutamatergic input to the striatum. The membrane
properties of the transplanted cells were consistent with the
membrane properties recorded from host striatal interneurons
(Kawaguchi, 1993), and similar to those observed in MGE-
derived interneurons transplanted into the cerebral cortex
(Alvarez-Dolado et al., 2006; Butt et al., 2005). Together, these
data support the conclusion that the majority of the transplanted
MGE cells become inhibitory interneurons that are synaptically
integrated into the host striatal circuitry.
MGECell Striatal Transplants Ameliorate the Behavioral
Symptoms of 6-OHDA-Lesioned Rats
To test the effect of transplanted MGE cells on the behavior of
6-OHDA-lesioned rats, we performed a series of behavioral tests
on each rat before and after transplantation or treatment
(Figure S1A available online) and analyzed the data via a 1-way
ANOVA model across time. We used week 5 as the baseline
time point and expressed the results for each of the subsequent
behavioral tests relative to the week 5 results. We performed
a series of multiple observations among groups: the 6-OHDA +
MGE cell group, the 6-OHDA and no transplant group, the
6-OHDA + sham surgery group, and finally the 6-OHDA + deadMGE cell group. The graphs display the change in behavior
from the baseline for each group.
Rotation under Apomorphine
Upon administration of apomorphine, rats with a unilateral
6-OHDA lesion rotate more to the contralateral side (with respect
to the lesioned side) than to the ipsilateral side. Control rats
rotate equally in both directions. For our studies, we followed
the convention of Ungerstedt and colleagues (Ungerstedt, 1971)
and considered the 6-OHDA-treated rats as hemi-Parkinsonian
when rotations to the contralateral side were at least four times
greater than rotations to the ipsilateral side. We compared the
number of contralateral rotations for the experimental and con-
trol groups and found that the number of rotations decreased
in the MGE-treated group (n = 18 rats) after transplantation,
but increased in the control groups (n = 12 rats; Figure 4A).
ANOVA showed that the difference between groups was statis-
tically significant at weeks 9, 11, and 14 (p < 0.01). Furthermore,
postcomparison tests showed that the MGE cell-treated group
rotated significantly less than the 6-OHDA and sham-injected
control (n = 11 rats) groups at 9, 11, and 14 weeks posttransplan-
tation, and significantly less than the dead MGE cell-injected
control group (n = 6 rats) at 11, 14, and 18 weeks. These results
indicate that transplantation of live MGE cells into the striatum
decreased apomorphine-induced rotations in 6-OHDA-lesioned
rats (Figure 4A).
Stride Length
We next compared the length of stride between experimental
and control groups to test the effects of MGE cell transplantation
on additional motor behaviors. The rats’ feet were dipped in black
ink and they were placed in a 1 m long runway that was covered
with paper to capture the rats’ footsteps (see Figures S1D–S1F).
We found that the length of stride of the 6-OHDA-treated rats
increased after MGE cell transplantation (n = 21 rats) and was
significantly longer than that of the 6-OHDA-treated (n = 12
rats), sham-injected (n = 11 rats), and dead MGE cell-injected
(n = 6 rats) control groups at week 11 (p = 0.02, Figure 4B).
MGE Cell Striatal Transplants Alter the Motor
Performance of Wild-Type Rats
The above results indicate that MGE cells transplanted into
6-OHDA-treated rats can modify their behavior. We next tested
whether MGE transplantation into the striatum of naive unle-
sioned animals had any effect. We transplanted MGE cells into
intact rats and examined their behavior via the assays described
above. The rotation under apomorphine test was not significantly
different in the naive rats injected with MGE cells (n = 6 rats)
compared to nontransplanted controls (n = 6 rats). In contrast,
the stride length of the naive rats that received MGE transplants
was significantly longer than that of control untreated rats
(p < 0.001, see Figure 5A). We also performed an open field
activity test in naive unlesioned control, 6-OHDA-injected, and
MGE-transplanted naive unlesioned rats. We tested the level of
motor activity in an open field during a 5 min period and found
that MGE cells transplanted into naive rats (no 6-OHDA
treatment) produced a level of activity (UM) that was significantly
higher (1101 ± 39 UM) than that in naive rats without any
treatment (912 ± 104 UM). We also found that 6-OHDA-injected
rats had lower motor activity levels than naive rats (453 ± 69 UM).
The increase of motor activity in naive rats that received MGE cellCell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc. 243
Figure 4. MGE Cell Transplantation Amelio-
rates the Behavioral Deficits of 6-OHDA
Lesions
(A) Rotation test. 6-OHDA-lesioned rats that
received MGE cell transplantation (n = 18) per-
formed fewer contralateral rotations under
apomorphine stimulation than nontransplanted
6-OHDA controls (n = 15), 6-OHDA-lesioned rats
that received sham injection (n = 11), or dead
MGE cells (n = 10). ANOVA showed that the differ-
ence between groups was significant at 9, 11, and
14 weeks (asterisks). Postcomparison analysis
showed that the MGE group rotated significantly
less than the 6-OHDA-treated control groups at
9, 11, and 14 weeks. Error bars depict standard
error of the mean.
(B) Length of stride test. 6-OHDA-lesioned rats that
received MGE cell transplantation (n = 18) had
a longer stride than did nontransplanted 6-OHDA
controls (n = 15) and 6-OHDA-lesioned rats that
received sham injection (n = 11). Naive rats (n = 10)
are included for comparison. ANOVA showed that
the difference between groups was significant at
11 weeks. Postcomparison analysis showed that
the MGE group had a significantly longer stride
than the 6-OHDA-lesioned control groups at
11 weeks (asterisk). See also Figure S1.
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MGE Cells Modify Striatal-Dependent Behaviortransplants versus naive rats is reflected in the open field zone
map (Figures 5B and 5C).MGE Cells Express D1 and D2 Dopamine Receptors
Apomorphine binds to dopamine receptors expressed by host
striatal neurons, which causes rotation in the 6-OHDA rat
(Ungerstedt and Arbuthnott, 1970). We found that apomor-
phine-induced rotational behavior was significantly reduced
after MGE transplantation. We asked whether the transplanted
MGE cells participated directly or indirectly in this response by
examining the expression of dopamine receptors by the trans-
planted MGE cells. We performed fluorescence immunostaining
for dopamine receptor 1 (DR1) and 2 (DR2) and detected the
presence of both receptors in the surface of cell soma andFigure 5. MGE Transplanted Cells Expressed Dopamine Receptors
(A1 and B1) MGE cells (green) expressed the dopamine receptor D1 (red) and do
(A2 and B2) Higher-magnification images showing that the MGE transplant cell (g
and processes. Merge panel shows colocalization.
Scale bars represent 30 mm for (A1) and (B1) and 3 mm for (A2) and (B2).
244 Cell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc.processes of MGE cells 12 weeks after transplantation (Figure 6).
These data suggest that apomorphine, and thus dopamine itself,
can directly stimulate MGE inhibitory interneurons, potentially
modifying rotational behavior and altering the balance of excita-
tion/inhibition in the striatum.MGE Cells Transplanted in the Subthalamic Nucleus
Do Not Migrate, but Survive and Differentiate
into Glial Cells
It has been suggested that increasing inhibition in the STN could
have beneficial effects in Parkinson’s disease (Benabid et al.,
2000; During et al., 2001). We therefore investigated whether
MGE cells transplanted in the STN survive and differentiate in
6-OHDA-lesioned rats. We characterized the MGE cells 4 weekspamine receptor D2 (red).
reen, white arrowhead) expresses D1 and D2 (red) on the somatic membrane
Figure 6. Transplantation of MGE Cells into
Control Rats that Had Not Been Lesioned
with 6-OHDA Increased the Length of Stride
and the Level of Activity
(A) The length of stride was significantly higher in
control rats injected with MGE cells (n = 6) than
in control rats (n = 16).
(B) Open field tests showed an increase in activity
for control animals that received MGE cell trans-
plantation in comparison to control rats.
Error bars depict standard error of the means.
(C) Representative open field zone maps from two
rats showing that transplantation of MGE cells into
control rats increased the level of motor activity
over that of control rats.
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planted into the STN did not migrate from the site of injection (n =
231 cells, analyzed in 6 rats; Figure 7A). This is in contrast to MGE
cells transplanted into striatum, which migrated substantial
distances from the site of injection. Moreover, MGE cells in the
STN did not differentiate into neurons; none of the 231 trans-
planted GFP-labeled MGE cells in the STN expressed the
neuronal marker NeuN. In contrast, a small number of MGE cells
located outside the boundary of the STN did express NeuN
(Figure 7B). None of the transplanted MGE cells in the STN
expressed the calcium-sequestering proteins CR or CB, or the
inhibitory interneuron markers GAD or GABA (Figures 7E and
7G–7I). The majority of MGE cells transplanted into the STN ex-
pressed the astrocyte marker GFAP (75% ± 5%, n = 151 cells). In
contrast, none of the MGE cells transplanted in the striatumFigure 7.
Nucleus
(A) MGE ce
survived bu
not mature
(B–K) None
STN expres
interneuron
sequesterin
planted into
(75% ± 5%
(30% ± 9%
STN expres
Scale bars
5 mm for (K
Cell Stem Cell 6, 238–2expressed GFAP. Roughly one-third of
the MGE cells in the STN also expressed
the oligodendrocyte marker CNPase
(30% ± 9%, n = 132 cells; Figures 7C,
7D, 7J, and 7K). We found that a small
percentage of MGE cells in the STN ex-
pressed the GABA transporter GAT1
(13% ± 5%, n = 94 cells; Figure 7F).
GAT-expressing cells are most likely
astrocytes or oligodendrocytes, which
have been shown to express the GAT1
transporter (Pow et al., 2005). These
data indicate that unlike the striatumwhere transplanted MGE cells differentiate into neurons and
integrate, most surviving MGE cells transplanted into the STN
become glial cells.
DISCUSSION
In this study we asked whether MGE cell transplantation could
be used to add inhibitory GABAergic interneurons to the striatum
and whether this approach might have a beneficial impact on the
motor behavior of 6-OHDA hemi-Parkinsonian rats. We trans-
planted MGE cells from E14.5 rats into the striatum of adult
rats. We found that a small population of these cells survived
at least 1 year after transplantation, migrated throughout the
striatum, differentiated into GABAergic neurons, and became
synaptically integrated into the striatal circuitry. We found thatMGA Cells Transplanted in the Subthalamic
lls transplanted into the subthalamic nucleus (STN)
t did not migrate from the site of injection and did
into neurons.
of the MGE cells that were transplanted into the
sed the neuronal marker NeuN (B), the inhibitory
marker GABA (E) or GAD (G), or the calcium
g proteins CR (H) or CB (I). Most MGE cells trans-
the STN expressed the astrocyte marker GFAP
, C and J) or the oligodendrocyte marker CNPase
, D and K). A small percentage of MGE cells in the
sed the GABA transporter GAT1 (13% ± 5%, F).
represent 25 mm in (A); 25 mm for (I) and (B)–(H); and
) and (J).
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lesioned rats improved motor scores on the apomorphine-stim-
ulated rotation test in this animal model of PD. We also noted that
MGE cell transplantation in the striatum increased the motor
activity of naive untreated control rats. The ability of MGE cells
to differentiate into interneurons appears to depend on the
host environment because MGE cells transplanted into the
STN differentiated into astrocytes and oligodendrocytes but
not neurons. Our data suggest that transplanting MGE cells
into striatum is a promising approach for modifying striatal-
dependent behaviors. These effects could be clinically relevant
in neurodegenerative conditions such as Parkinson’s disease.
Transplanted MGE Cells Differentiate into Inhibitory
Interneurons that Functionally Integrate
into the Striatum
We found that MGE cells transplanted into the striatum survive at
least 1 year, migrate from the site of injection, and are widely
distributed throughout the striatum. Previous studies have also
explored the potential of MGE cell transplantation in the striatum.
For example, Campbell et al. (1995) injected MGE cells into the
lateral ventricle of embryonic mice and found that while some
of the transplanted cells survived, they did not migrate into the
striatum. Olsson et al. (1997) transplanted mouse E13.5–E14
MGE cells into the striatum of postnatal day 1, 7, and 21 rats
and reported that the cells distributed widely throughout the
striatum. Wichterle et al. (1999) transplanted mouse neuronal
precursor cells from the MGE, LGE, and cortical ventricular
zone into the adult striatum and found that only MGE cells
possessed a unique capacity to migrate and differentiate into
neurons. Alvarez-Dolado et al. (2006) showed that MGE cells
transplanted into postnatal day 3 and 4 striatum differentiated
into GABA+ neurons. We confirmed these findings and further
demonstrate that MGE cells transplanted into the adult striatum
acquire a mature morphological phenotype and differentiate into
GABAergic neurons that express markers common to striatal
interneurons. Although a small percentage of the transplanted
MGE cells survived, their impact on behavior depends on
a number of factors including the number of surviving MGE
interneurons relative to the normal number of host striatal
interneurons. Stereological-based studies estimate that there
are approximately 49,000 striatal interneurons in the adult rat:
13,000 CR+ interneurons (Rymar et al., 2004), 15,000 PV+ inter-
neurons (Larsson et al., 2001; Luk and Sadikot, 2001), and
21,000 SOM+ interneurons (West et al., 1996). Therefore, the
average number of transplanted MGE cells that survived in our
experiments (2613 ± 156 cells, n = 3 rats) could represent up
to 5% of the total number of host striatal interneurons. Along
with surviving cell numbers, integration of transplanted cells
into host tissue is another factor that determines their impact
on host behavior. We find that the transplanted MGE cells extend
numerous processes throughout the striatum, and our electro-
physiological recordings demonstrate that surviving MGE cells
integrate within the striatal circuitry. Finally, our behavioral tests
show that transplanted MGE cells result in changes in motor
behavior in both 6-OHDA-treated and untreated animals. Future
studies should explore whether the transplantation of more MGE
cells would yield a greater number of surviving interneurons in
the host striatum and whether this would have a positive impact246 Cell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc.on motor behavior in animal models of PD. In addition, future
studies should test the transplantation of multiple cell types to
examine for synergistic benefits that could impact different
facets of PD.
The embryonic MGE produces striatal and neocortical inter-
neurons that share the expression of several markers (Defelipe
et al., 1999; Kawaguchi, 1997; Kubota et al., 1994). Thus, it is
likely that the transplanted MGE cells included cells destined
to populate both the striatum and the neocortex and that the
MGE cells that survived in the striatal transplants are those
that had molecular expression characteristics of striatal inter-
neurons. However, we cannot exclude the possibility that the
host environment in the striatum also influenced MGE cell fate
and marker expression after transplantation. We noted that
none of the MGE cells that survived after transplantation in the
adult STN express neuronal markers, but many express the
astrocyte marker GFAP, which was not expressed by MGE cells
after transplantation in the striatum. These data highlight the
importance of local environmental cues for the survival and/or
fate determination of transplanted MGE cells.
We did not detect GFP+ processes outside of the striatum in
the transplanted animals, indicating that the transplanted MGE
cells did not differentiate into GABAergic projection neurons.
This suggests that the MGE cells integrated within the circuitry
of the striatum and that the behavioral changes we observed in
transplanted rats may have been due to modification of activity
of synapses and/or neurons within the striatum. This could
have impacted the activity level of host GABAergic interneurons
and/or projection neurons. Future studies will be needed to
further understand the physiological integration of MGE cells
after transplantation into the adult striatum.
Transplanted MGE Cells Alter Motor Behavior
in 6-OHDA-Lesioned and Control Rats
We observed behavioral changes in 6-OHDA-lesioned rats that
received MGE cell transplantation, including improved motor
scores in the apomorphine rotational test and a temporary
increase in the length of stride. These behavioral changes
suggest a general improvement of the motor symptoms in
6-OHDA-treated rats after MGE transplantation. A recent study
has shown that depriving the striatum of dopaminergic inputs
from the substantia nigra creates an imbalance in local circuits
that involve GABAergic striatal neurons (Mallet et al., 2006).
Previous attempts have been made to modulate basal ganglia
activity by enhancing GABA stimulation in animal models of Par-
kinson’s disease. For example, GABA-rich striatal tissue has
been transplanted in the substantia nigra of 6-OHDA rats and
the tissue survived and induced functional recovery (Winkler
et al., 1999). During et al. introduced the gene for the GABA-
synthesizing enzyme GAD 65 into the STN of humans through
a recombinant adeno-associated viral vector and observed
a slower degeneration of dopaminergic neurons (During et al.,
2001; Kaplitt et al., 2007). Additionally, gene therapy studies in
a rat model of Parkinson’s disease that introduced GAD 65
into the STN reported a strong neuroprotective effect on nigral
dopaminergic neurons and rescue of the Parkinsonian behav-
ioral phenotype (Lee et al., 2005; Luo et al., 2002). It has recently
been shown that striatal interneurons play key roles in basal
ganglia function and related disorders by modulating the activity
Cell Stem Cell
MGE Cells Modify Striatal-Dependent Behaviorof striatal projection neurons (Salin et al., 2009). In the experi-
mental stroke animal model, transplanted MGE cells migrated
toward lesioned areas of the striatum, integrated into the local
circuitry, and rescued motor deficits (Daadi et al., 2009). In the
present study, we transplanted MGE cells 6 weeks after the
6-OHDA-induced lesion. We found that the MGE cells differenti-
ated into GABA+ interneurons within 4 weeks after transplanta-
tion and notably improved motor behavior in the 6-OHDA rat
model of PD. These results suggest that, in addition to the
protective effect described previously, GABAergic cells may be
able to improve PD symptoms once the disease is established.
Furthermore, the increase in motor behavior that we observed
after transplantation of embryonic MGE cells into the striatum
of naive control rats indicates that MGE cells may be capable
of modifying the intrinsic balance of excitatory and inhibitory
signals in the striatum, and thus represent a novel strategy for
altering output of the striatum in disease conditions.
The ability of MGE cells to disperse in the striatum, mature,
and become functionally integrated into basal ganglia circuitry
is probably responsible for the behavioral modifications we
observed both in the 6-OHDA-treated and control animals. Our
findings are consistent with the interpretation that the trans-
planted MGE cells release GABA, and this alters the balance of
striatal activity to produce behavioral modifications. If this
hypothesis is correct, transplanted GABAergic cells would
presumably hyperpolarize host striatal neurons and reduce their
rate of firing, decrease their inhibitory influence on target cells,
and as a result increase the net excitatory output of the basal
ganglia. However, other mechanisms could potentially explain
the changes in motor behavior we observed after MGE cell trans-
plantation. Our results are similar to those showing that L-dopa
administration increases open field activity levels in control rats
(Dahl and Go¨testam, 1989; Ljungberg and Ungerstedt, 1976).
Thus, it is also possible that the transplantation of MGE cells
induced secondary changes in the striatum that produced or
contributed to the behavioral changes (Goto et al., 1997). This
possibility is supported by our observation that there was a
temporary increase in CB expression by host striatal cells at
the site of MGE cell transplantation. It is also possible that the
presence of exogenous MGE cells in the adult striatum could
have trophic effects and stimulate process outgrowth of host
striatal neurons or remaining host dopaminergic processes in
the striatum, which could then increase motor activity, although
staining for TH did not show an obvious increase. Another possi-
bility is that nonneuronal MGE cells may also have a functional
effect. Specifically, the 25% of transplanted MGE cells that
matured into oligodendrocytes could release trophic factors
such as GDNF, which is known to stimulate regeneration and
sprouting of SN neurons (Du and Dreyfus, 2002; Wilkins et al.,
2003). Further studies will be required to elucidate the mecha-
nism(s) that produced the altered motor behaviors we observed
in the 6-OHDA-treated rats and to explore the full range of
cellular effects in the MGE transplant model. Future experimen-
tation in animal models may help determine if there are optimal
transplantation sites within the striatum, and experiments to
derive MGE-like cells from embryonic stem cells may help over-
come potential obstacles such as obtaining a sufficient supply of
embryonic MGE cells. MGE cell transplants survive for more than
1 year in the rat and exhibit widespread integration in the adultstriatum with functional consequences. Future studies should
further explore the clinical potential of these embryonic cells.
EXPERIMENTAL PROCEDURES
Experimental Design
We performed the 6-OHDA lesions on experimental day 1 and behavioral tests
at weeks 3 and 5 to select Parkinsonian rats. MGE cells were transplanted at
week 6, and behavioral tests were repeated at weeks 9, 11, 14, and 18
(Figure S1A). All animals were treated in accordance with protocols approved
by the Institutional Animal Care and Use Committee at UCSF.
6-OHDA Model
We performed a unilateral lesion of the nigrostriatal projection in rats, by using
6-OHDA, which leads to the loss of dopaminergic cells in the SNc through
retrograde transport and loss of dopaminergic terminals in the striatum
through axonal disruption (Berger et al., 1991). We perfused a subset of
animals (n = 5) 4 weeks after lesion and immunostained the SNc for tyrosine
hydroxylase (TH), a rate-limiting enzyme in the synthesis of dopamine, to label
dopaminergic cells. The SNc ipsilateral to the 6-OHDA injection did not have
TH+ cells or processes, whereas the contralateral side retained the normal
TH+ cell components (Figure S1B). To evaluate the 6-OHDA surgeries
in vivo, we performed behavioral testing as described below.
6-OHDA Surgery
Adult female rats (n = 75) were anesthetized with ketamine (90 mg/kg) and
xylazine (7 mg/kg) and immobilized within a stereotaxic frame in flat skull posi-
tion. The coordinates for the nigrostriatal bundle were determined based on
the Paxinos and Watson adult rat brain atlas (Paxinos and Watson, 1982).
A midsagittal skin incision was made on the scalp, a hole was drilled through
the skull, and a glass capillary micropipette with a 50 mm diameter tip was
located within the nigro-striatal pathway. The micropipette was filled with
a solution of 6-OHDA (Sigma, MO): 0.5 ml of 6-OHDA (4 mg/ml) plus 0.02%
ascorbic acid in saline. The 6-OHDA solution was slowly injected and the
micropipette was kept at the site for an additional 4 min. The wound was
cleaned and closed. Each animal was injected with 6-OHDA on the right
side only, producing hemi-Parkinsonian rats. After surgery, an analgesic
(buprenorphine hydrochloride, 0.1 ml of 0.3 mg/ml) and an anti-inflammatory
(meloxicam, 0.1 ml of 1.5 mg/ml) were subcutaneously injected.
MGE Transplant Surgery
Adult pregnant rats that expressed the green fluorescent protein (EGFP) under
the chick-beta actin promoter (Wistar-TgN [CAG-GFP, 184Ys, Rat Resource
and Research Center]) were anesthetized as described above. Fetuses were
removed from the uterus at E14.5. Fetal brains and MGEs were dissected in
oxygenated artificial cerebrospinal fluid (aCSF, in mm: NaCl, 125; KCl, 2.5;
MgCl2, 1; CaCl2, 2; NaPO4, 1.25; NaHCO3, 25; and glucose, 25; Sigma). The
MGE from both hemispheres of four animals was used to prepare dissociated
cells for each surgery. The MGE tissue was mechanically dissociated in the
presence of 1% DNase I in aCSF. Cells were centrifuged at 23 gravity for
2 min, and pellets were dissociated in 5 ml of aCSF. Immediately after dissoci-
ation, three injections were performed along the rostro-caudal axis of the stria-
tum, and cells were deposited at three delivery sites along the dorsal-ventral
axis at each injection site. 400 nl of cell suspension was injected at each
delivery site for a total of 3.6 ml of MGE cell suspension injected each time.
One 300 nl injection was performed into the subthalamic nucleus (STN). The
total number of transplanted cells averaged 252,390 ± 7,729. Sham injections
were performed as described above but only aCSF vehicle was injected. Dead
MGE cells were obtained by freezing the MGE cell suspension at 20C for
5 min, followed by 5 min at 37C, and this cycle was repeated eight times
(Modo et al., 2003).
Immunocytochemistry
Rats were anesthetized and perfused intracardially with 0.1 M phosphate
buffer saline (PBS) followed by 4% paraformaldehyde in PBS at 4C (PFA).
The brains were removed and postfixed 24 hr in PFA. Coronal 50 mm slices
were prepared on a vibratome (Leica). Free-floating sections were blockedCell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc. 247
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USA), and 0.2% gelatin (Sigma). Sections were incubated 24 hr in primary
antibodies at room temperature. The primary antibodies were: anti-neuronal
specific nuclear protein (mouse anti-NeuN, 1:1000, Chemicon), gamma
aminobutyric acid (rabbit anti-GABA, 1:1000, Sigma), glutamic acid decarbox-
ylase 67 (mouse anti-GAD, 1:1000, Abcam), GABA transporter 1 (rabbit
anti-GAT, 1:300, Abcam), CNPase (mouse anti-CNPase, 1:500, Abcam), glial
fibrillary acidic protein (rabbit anti-GFAP, 1:1000; Sigma), substance P (rabbit
anti-SP, 1:2000, Chemicon), somatostatin (mouse anti-Som, 1:100, Abcam),
nitric oxide synthase (rabbit anti-NOS, 1:100, Abcam), choline acetyltransfer-
ase (rabbit anti-Chat, 1:500; Chemicon), tyrosine hydroxylase (mouse anti-TH,
1:1000, Boehringer Mannheim Biochemica), parvalbumin (mouse anti-PV,
1:1000, Chemicon), calretinin (mouse anti-CR, 1:1000; Chemicon), calbindin
(mouse anti-CB, 1:2000; Swant, Bellinzona, Switzerland), synaptophysin
(mouse anti-Synaptophysin, 1:200, Sigma), dopamine- and cAMP-regulated
protein (rabbit anti-DARPP 32, 1:50, Abcam), dopamine transporter (rat anti-
DAT, 1:500, Abcam), vesicular monoamine transporter 2 (rabbit anti-VMAT,
1:1000, Abcam), dopamine receptor 1 (rabbit anti-DR1, 1:2000, Abcam),
dopamine receptor 2 (rabbit anti-DR2, 1:500, Abcam), and green fluorescent
protein (chicken anti-GFP, 1:1000, Abcam). Sections were rinsed and incu-
bated in the appropriate secondary antibody: Cy2, Cy3, or Cy5 conjugated
polyclonal anti-mouse/goat/rabbit antibodies (1:100, Jackson Laboratories,
ME, USA). Tissue was rinsed and mounted on coated glass slides and cover-
slipped with an aqueous mounting medium (Aquamount; Lerner, PA, USA).
Confocal microscopy was performed on an Olympus Fluoview confocal laser
scanning microscope and analysis performed in Fluoview v.3.3 (Olympus). We
omitted the first antibody as a control for each immunostaining experiment.
Cell Quantification
The survival of MGE cells after transplantation and the percentage of trans-
planted MGE cells that expressed cell-specific markers were quantified
through confocal microscopy. Brains were perfused and cut into 50 mm thick
coronal sections. The number of MGE cells that survived transplantation was
estimated by counting the number of cells in every third 50 mm thick section
throughout the rostro-caudal axes of the brain and multiplying this number
by three. The percentage of MGE-transplanted cells that expressed cell-
type-specific markers was calculated with at least three animals for each
marker (n = 27 total animals analyzed). MGE cells were counted in three
coronal sections: one section at the level of a MGE cell transplantation,
a second section 300 mm rostral to the injection, and a third section 300 mm
caudal to the site of injection.
Electrophysiology
Coronal slices for electrophysiological recordings of GFP+ MGE-transplanted
cells were prepared as described previously (Noctor et al., 2008). In brief,
brains were sectioned at 400 mm with a vibratome (Leica) in ice-chilled aCSF
containing (in mM) 25 glucose, 3 KCl, 1.25 NaH2PO4, 2 MgSO4, 26 NaHCO3,
and 10 dextrose, saturated with 95% O2/5% CO2. Slices were incubated at
32C for 30 min after slicing in NaCl-based ACSF containing (in mM)
126 NaCl, 3 KCl, 1.25 NaH2PO4, 2 MgSO4, 26 NaHCO3, 10 dextrose, and
2 CaCl2, saturated with 95% O2/5% CO2. Slices were held at room tempera-
ture until being moved to a 32C submersion-type chamber on an Olympus
BX50WI upright microscope. GFP+ cells were identified under epifluorescence
and recordings performed with either an EPC-9 patch-clamp amplifier (Heka
Electronics) controlled by an Apple computer running Pulse v8.0 (Heka) or
pClamp version 10 (Axon Instruments). Patch pipettes were made from
1.5 mm OD/1.0 mm ID glass (Corning) and filled with (in mM) 130 K-gluconate,
4 KCl, 2 NaCl, 10 HEPES, 0.2 EGTA, 4 ATP-Mg, 0.3 GTP-disodium, 14 phos-
phocreatine-dipotassium (pH 7.25, 280–290 mOsm). For morphological
reconstruction, 50 mM Texas Red dextran (Molecular Probes) was included
in the recording solution. For measurement of miniature synaptic currents,
K-gluconate was replaced with KCl and osmolarity was adjusted with sucrose.
GABAergic and glutamatergic minis were isolated in ACSF containing TTX
(0.5 mM, Calbiochem) with bicuculline methiodide (100 mM, Sigma) and
DNQX (20 mM, Tocris) with an Octaflow drug application system (ALA Scientific
Instruments, Inc.). Series resistances were typically between 5 and 15 MU and
were continually monitored and compensated for throughout the recording
sessions. Voltages were corrected for a 14 mV liquid junction potential.248 Cell Stem Cell 6, 238–250, March 5, 2010 ª2010 Elsevier Inc.Recordings were performed with a MultiClamp 700B amplifier (Axon Instru-
ments) under infrared-differential interference contrast visualization with an
Olympus BX50WI and a CCD camera (MTI). Glass recording electrodes
(7–10 MU) were filled with (in mM): KCl 130, NaCl 5, CaCl2 0.4, MgCl2 1, HEPES
10 [pH 7.3], EGTA 1.1, to which 500 mM Alexa 594-conjugated biocytin (Molec-
ular Probes) was added to identify recorded cells. Recordings were acquired
and analyzed with pClamp version 10 (Axon Instruments) and data were further
analyzed in Excel (Microsoft, Inc.) and Mini Analysis (Synaptosoft). All averages
reported appear as mean ± standard error. Resting membrane potential was
measured immediately after breaking into whole-cell recording mode. Input
resistance was calculated from small (3–5 mV) 600 ms voltage deflections
induced by square hyperpolarizing current injections (averages of 20–40
deflections). Estimates of the membrane time constant were obtained by fitting
an exponential function to these same hyperpolarizing voltage deflections.
Input capacitance was calculated by dividing the time constant by the input
resistance. Epifluorescent images of the recorded cells were collected with
Scion Image and arranged with Photoshop.
Behavioral Tests
We performed behavioral tests at 3 and 5 weeks after the 6-OHDA surgeries;
MGE cell, sham, and dead cell transplants were performed at week 6; and
behavioral tests were repeated on weeks 9, 11, 14, and 18.
Rotational Behavior
Drug-induced rotations were measured in an automated rotometer bowl 28 cm
in diameter 3 36 cm high (Columbus Instruments, OH) (Ungerstedt and
Arbuthnott, 1970). After intraperitoneal injection of apomorphine (0.05 mg/
kg, i.p.), the animals were fitted with a jacket that was attached to a rotation
sensor and placed in the test bowl. The number and direction of rotations
was recorded over a test period of 40 min (Figure S1C). Apomorphine stimu-
lates dopaminergic receptors directly, preferentially on the denervated side
resulting from denervation-induced dopamine receptor supersensitivity,
causing contralateral rotation (Creese et al., 1977; Ungerstedt, 1971; Unger-
stedt and Arbuthnott, 1970). There is a threshold of SNc damage that must
be reached in order to produce maximal rotation behavior after apomorphine
administration (Hudson et al., 1993). The abnormal behavior of hemi-Parkinso-
nian rats is directly related to the amount of DA cell loss. We observed that less
than 50% dopamine depletion in the striatum did not yield a significant change
in rotation behavior after apomorphine injection, because of compensatory
mechanisms in the striatum. For our experiment we selected only those
6-OHDA rats that rotated at least four times more to the contralateral than to
the ipsilateral side of the injection.
Stride Test
The test animal was placed on a runway 1 m long and 33 cm wide with walls
50 cm high on either side. A dark enclosure was placed at one end of the
runway, and rats were free to enter the enclosure after traversing the runway.
Rats were trained to run down the runway by placing them on the runway at the
end opposite to the dark enclosure. The floor of the runway was covered with
paper. At the start of each test, the animals’ rear feet were dipped in black ink
before being placed at the beginning of the runway. We repeated the test twice
for each rat, measured the length of stride for each test, and obtained an
average stride length for each rat. We compared the average stride length
across groups. 6-OHDA rats display impairments in the posture and move-
ment of the contralateral limbs (Figures S1D and S1E).
Open Field Test
We used an Open Field 16 3 16 Photobeam System with Flex-Field software
(40 cm wide, 40 cm deep, and 37.5 cm high, SD. Instruments). Each animal
was placed in the center of the enclosure at the start of the test and allowed
to freely explore the apparatus for 5 min. The Flex-Field software recorded
units of movement, which were represented by the number of entries into
each of the 256 square zones of the open field, and the amount of time spent
at each point. At the end of the experiment, the movement of each rat during
the 5 min period was represented as units of movement and by a zone map
that traced the path followed by the rat in the open field.
Statistical Analysis
Data were analyzed with a 2-way ANOVA model with time and group (6-OHDA,
6-OHDA + MGE cells, 6-OHDA + sham surgery, and 6-OHDA + dead MGE
cells) as factors. We ran a set of multiple comparisons for each dependent
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means (LSMeans), comparing groups averaged across time, or groups within
each time point, expressed relative to the baseline observation. The results
were expressed in terms of dependent variable (the response measure), the
time point being analyzed relative to the baseline value, the p value for overall
ANOVA, and the multiple comparisons. Because of the existence of occa-
sional outliers (extreme observations), the rotation data did not satisfy the
ANOVA assumption that the residual errors were normally distributed. To
address this issue, the rotation data (the number of turns in the contralateral
direction) was log-transformed. We ran behavioral tests on two time points
before MGE treatment (weeks 3 and 5) and on four time points after MGE treat-
ment (weeks 9, 11, 14, and 18). We used the week 5 observation time point as
the baseline point and expressed the results of each subsequent behavioral
test relative to the week 5 results. We performed a series of multiple observa-
tions among the four groups (6-OHDA, 6-OHDA + MGE cells, 6-OHDA + sham
surgery, and 6-OHDA + dead MGE cells). Graphs display the change from
base line measures.
SUPPLEMENTAL INFORMATION
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